TY - JOUR
T1 - Factors related to adverse events during endovascular coil embolization for ruptured cerebral aneurysms
AU - Imamura, Hirotoshi
AU - Sakai, Nobuyuki
AU - Satow, Tetsu
AU - Iihara, Koji
N1 - Funding Information:
Competing interests hi received speakers’ Bureau/honoraria from Medtronic co. ns received speakers’ Bureau/honoraria from Otsuka Pharmaceutical co, stryker co, Medtronic co, Medico’s hirata co, and Biomedical solutions co, and research funding from Otsuka Pharmaceutical co, Terumo co, and Daiichi sankyo co. Ki received speakers’ Bureau/honoraria from Otsuka Pharmaceutical co, and research funding from Otsuka Pharmaceutical co, Mitsubishi Tanabe Pharma co, Kaneka Medix co, chugai Pharmaceutical co, and eizai co.
Funding Information:
Funding This study was supported in part by a grant-in-aid (Junkanki-Kaihatsu h24-4-3) from the national cerebral and cardiovascular center, Japan and by hatazaki Foundation, Kobe, Japan.
Publisher Copyright:
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
PY - 2020/6/1
Y1 - 2020/6/1
N2 - Background and purpose The risk factors for adverse events for example, intraprocedural rupture (IPR), ischemic complication within 24 hours, and rebleeding after endovascular coil embolization for a ruptured cerebral aneurysm remain unclear. The aim of this study was to identify significant associated risk factors. Methods We retrospectively evaluated data from 5358 patients listed on the Japanese Registry of Neuroendovascular Therapy 3 during 2010-2014. Results IPR, ischemic complications, and rebleeding occurred during or after 221 (4.1%), 226 (4.2%), and 63 (1.2%) treatments, respectively. All of the adverse events were significantly associated with the patients' poor outcomes at 30 days. Multivariate analysis revealed the factors independently related to these adverse events as follows: (1) for IPR: female sex, bifurcation type, <5 mm aneurysm, emergent surgery, local anesthesia, a balloon-assisted technique; (2) for an ischemic complication: poor World Federation World Federation of Neurological Societies (WFNS) grade, wide neck, and stent-assisted technique; (3) for rebleeding: poor WFNS grade, bifurcation type, wide neck, and body filling as the initial result. Conclusions Knowledge of the risk factors of endovascular coil embolization and paying attention to them are essential for patients' safe treatment and good outcomes.
AB - Background and purpose The risk factors for adverse events for example, intraprocedural rupture (IPR), ischemic complication within 24 hours, and rebleeding after endovascular coil embolization for a ruptured cerebral aneurysm remain unclear. The aim of this study was to identify significant associated risk factors. Methods We retrospectively evaluated data from 5358 patients listed on the Japanese Registry of Neuroendovascular Therapy 3 during 2010-2014. Results IPR, ischemic complications, and rebleeding occurred during or after 221 (4.1%), 226 (4.2%), and 63 (1.2%) treatments, respectively. All of the adverse events were significantly associated with the patients' poor outcomes at 30 days. Multivariate analysis revealed the factors independently related to these adverse events as follows: (1) for IPR: female sex, bifurcation type, <5 mm aneurysm, emergent surgery, local anesthesia, a balloon-assisted technique; (2) for an ischemic complication: poor World Federation World Federation of Neurological Societies (WFNS) grade, wide neck, and stent-assisted technique; (3) for rebleeding: poor WFNS grade, bifurcation type, wide neck, and body filling as the initial result. Conclusions Knowledge of the risk factors of endovascular coil embolization and paying attention to them are essential for patients' safe treatment and good outcomes.
UR - http://www.scopus.com/inward/record.url?scp=85084922933&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85084922933&partnerID=8YFLogxK
U2 - 10.1136/neurintsurg-2019-015459
DO - 10.1136/neurintsurg-2019-015459
M3 - Article
C2 - 31980542
AN - SCOPUS:85084922933
SN - 1759-8478
VL - 12
SP - 605
EP - 609
JO - Journal of NeuroInterventional Surgery
JF - Journal of NeuroInterventional Surgery
IS - 6
ER -